Cryoablation Study for Mesothelioma Opening at UCLA
Researchers at UCLA Jonsson Comprehensive Cancer Center will soon begin studying the pre-surgery use of cryoablation as a potential early adjuvant therapy for patients with pleural mesothelioma.
The pilot study will measure immune system stimulation through local tumor infiltration in hopes of extending patient survival in the future.
Cryoablation, also known as cryotherapy or cryosurgery, freezes localized tumors with liquid nitrogen or argon gas. It has been proven effective in killing tumor cells with extreme cold.
“The idea is possibly buying additional time after surgical resection by minimizing chances of recurrence, or giving the body a head start in fighting that recurrence,” Dr. Neema Jamshidi, diagnostic radiologist at UCLA, said. “We hope to better understand the effect of cryoablation with mesothelioma.”